Skip to main content
. 2009 Nov 20;192(4):942–948. doi: 10.1128/JB.01259-09

TABLE 3.

Effect of GyrA on antibiotic susceptibility of strain SPC105

Treatment (μM) Relative survival (%)a
No plasmid pSPOK-gyrA pDrive-gyrA
No treatment 100 96 98
Nalidixic acid
    100 55 57 15
    300 30 56 NT
    400 8 33 NT
Norfloxacin
    0.5 64 82 3
    1.25 20 51 NT
    1.5 5 13 NT
Chloramphenicol
    7 88 100 45
    42 48 100 NT
    70 28 75 NT
Tetracycline
    1 90 100 37
    2 53 100 NT
    6 14 50 NT
a

NT, not tested. pSPOK-gyrA, overexpression of GyrA; pDrive-gyrA, reduced expression of GyrA.